Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arvind Shah

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Metabolic Syndrome and Related Disorders|December 2, 2010
Effects of coadministered ezetimibe plus fenofibrate in mixed dyslipidemic patients with metabolic syndromeHarold E Bays, Arvind Shah, Geraldine Macdonell, et al.
Current Pharmaceutical Design|November 30, 2016
Glaucoma: Hot Topics in PharmacologyShiama I Balendra, Parth Arvind Shah, Mishank Jain, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 17, 2012
Consistency of extended-release niacin/laropiprant effects on Lp(a), ApoB, non-HDL-C, Apo A1, and ApoB/ApoA1 ratio across patient subgroupsHarold E Bays, Arvind Shah, Jianxin Lin, et al.
International Ophthalmology|March 18, 2026
Incidences and outcomes of retinal re-detachment in vitrectomised eyes following cataract extractionParth Arvind Shah, Neil Shah, Syed Ahmed, et al.
Current Medical Research and Opinion|September 24, 2004
Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndromeLeon Simons, Melvin Tonkon, Luis Masana, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 13, 2018
Oculo-visual abnormalities in Parkinson's disease: Possible value as biomarkersLi Guo, Eduardo M Normando, Parth Arvind Shah, et al.
Journal of Clinical Lipidology|December 3, 2010
Efficacy and tolerability of extended-release niacin/laropiprant in dyslipidemic patients with metabolic syndromeHarold E Bays, Arvind Shah, Jianxin Lin, et al.
Metabolic Syndrome and Related Disorders|March 29, 2008
Efficacy and safety of ezetimibe/simvastatin co- administered with fenofibrate in mixed hyperlipidemic patients with metabolic syndromeBlas Gil-Extremera, Gustavo Mendez, Michelle Zakson, et al.
Lipids in Health and Disease|August 24, 2011
Response by sex to statin plus ezetimibe or statin monotherapy: a pooled analysis of 22,231 hyperlipidemic patientsBeth L Abramson, Pascale Benlian, Mary E Hanson, et al.
JNMA; Journal of the Nepal Medical Association|September 24, 2020
Stone Clearance by Computed Tomography after Percutaneous Nephrolithotomy: A Descriptive Cross-sectional StudyChitaranjan Shah, Robin Bahadur Basnet, Arvind Shah, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Metabolic Syndrome and Related Disorders|December 2, 2010
Effects of coadministered ezetimibe plus fenofibrate in mixed dyslipidemic patients with metabolic syndromeHarold E Bays, Arvind Shah, Geraldine Macdonell, et al.
Current Pharmaceutical Design|November 30, 2016
Glaucoma: Hot Topics in PharmacologyShiama I Balendra, Parth Arvind Shah, Mishank Jain, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 17, 2012
Consistency of extended-release niacin/laropiprant effects on Lp(a), ApoB, non-HDL-C, Apo A1, and ApoB/ApoA1 ratio across patient subgroupsHarold E Bays, Arvind Shah, Jianxin Lin, et al.
International Ophthalmology|March 18, 2026
Incidences and outcomes of retinal re-detachment in vitrectomised eyes following cataract extractionParth Arvind Shah, Neil Shah, Syed Ahmed, et al.
Current Medical Research and Opinion|September 24, 2004
Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndromeLeon Simons, Melvin Tonkon, Luis Masana, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 13, 2018
Oculo-visual abnormalities in Parkinson's disease: Possible value as biomarkersLi Guo, Eduardo M Normando, Parth Arvind Shah, et al.
Journal of Clinical Lipidology|December 3, 2010
Efficacy and tolerability of extended-release niacin/laropiprant in dyslipidemic patients with metabolic syndromeHarold E Bays, Arvind Shah, Jianxin Lin, et al.
Metabolic Syndrome and Related Disorders|March 29, 2008
Efficacy and safety of ezetimibe/simvastatin co- administered with fenofibrate in mixed hyperlipidemic patients with metabolic syndromeBlas Gil-Extremera, Gustavo Mendez, Michelle Zakson, et al.
Lipids in Health and Disease|August 24, 2011
Response by sex to statin plus ezetimibe or statin monotherapy: a pooled analysis of 22,231 hyperlipidemic patientsBeth L Abramson, Pascale Benlian, Mary E Hanson, et al.
JNMA; Journal of the Nepal Medical Association|September 24, 2020
Stone Clearance by Computed Tomography after Percutaneous Nephrolithotomy: A Descriptive Cross-sectional StudyChitaranjan Shah, Robin Bahadur Basnet, Arvind Shah, et al.
Pageof 4